Evidence map›Paper›PMID 33194571›Full record

ArticleFrontiers in oncology2020

Low-Grade Adenosquamous Carcinoma of the Axilla of Breast Origin in a Male: A Case Report and Literature Review.

Xingqiang Yan, Fanshuang Zhu, Qiupeng Wang, Lijie Chen, Yixing Zhou, Zenggui Wu, Linhang Mei, Zhaosheng Ma, Binbin Cui, Feilin Cao

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Xingqiang YanDepartment of Surgical Oncology, Taizhou Hospital, Wenzhou Medical University, Wenzhou, China.
Fanshuang ZhuDepartment of Surgical Oncology, Taizhou Hospital, Wenzhou Medical University, Wenzhou, China.
Qiupeng WangDepartment of Pathology, Taizhou Hospital, Wenzhou Medical University, Wenzhou, China.
Lijie ChenDepartment of Surgical Oncology, Taizhou Hospital, Wenzhou Medical University, Wenzhou, China.
Yixing ZhouDepartment of Surgical Oncology, Taizhou Hospital, Wenzhou Medical University, Wenzhou, China.
Zenggui WuDepartment of Surgical Oncology, Taizhou Hospital, Wenzhou Medical University, Wenzhou, China.
Linhang MeiDepartment of Surgical Oncology, Taizhou Hospital, Wenzhou Medical University, Wenzhou, China.
Zhaosheng MaDepartment of Surgical Oncology, Taizhou Hospital, Wenzhou Medical University, Wenzhou, China.
Binbin CuiDepartment of Surgical Oncology, Taizhou Hospital, Wenzhou Medical University, Wenzhou, China.
Feilin CaoDepartment of Surgical Oncology, Taizhou Hospital, Wenzhou Medical University, Wenzhou, China.
Wenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low-grade adenosquamous carcinoma (LGASC) is a rare invasive tumor that occurs in breast parenchyma. It has previously only been reported in females. Herein, we describe the case of a 52-year-old male who presented with a palpable mass in his right axilla that he reported had been present for 20-years. This is the first report of a male patient with LGASC. Core needle biopsy pathology revealed a benign mass of mammary origin, but its type was initially misdiagnosed. It was only correctly identified via postoperative pathology after local excision, which indicated that the mass exhibited the typical pathological characteristics of LGASC. Immunohistochemical analysis revealed positive expression of estrogen receptor, which was inconsistent with the typical "triple-negative" immunophenotype of LGASC. After resection of the mass the patient was advised to participate in regular outpatient follow-up. In conclusion, LGASC should be considered in male patients with a mass lesion in their breast or axilla, even when core needle biopsy indicates a benign mass of breast origin. One-stage local resection is recommended for the treatment of male patients with LGASC, but it is crucial to ensure that the margins are negative and postoperative adjuvant radiotherapy is not recommended.

Indexed as

breastcancerestrogen receptorlow-grade adenosquamous carcinomametaplastic carcinoma

Identifiers

PMID33194571
PMCPMC7662442
OpenAlexW3095385946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.